Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Kidney360|June 30, 2021
Shaping Up Mitochondria in Diabetic NephropathyKoki Mise, Daniel L Galvan, Farhad R Danesh
Kidney International|September 13, 2017
The hallmarks of mitochondrial dysfunction in chronic kidney diseaseDaniel L Galvan, Nathanael H Green, Farhad R Danesh
Current Opinion in Nephrology and Hypertension|July 27, 2022
Electrolytes disturbances in cancer patientsAnna Turcotte, Sai Achi, Omar Mamlouk, et al.
Biomacromolecules|March 23, 2011
Injectable multidomain peptide nanofiber hydrogel as a delivery agent for stem cell secretomeErica L Bakota, Yin Wang, Farhad R Danesh, et al.
Diabetes|December 18, 2007
Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose controlVasantha Kolavennu, Lixia Zeng, Hui Peng, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 17, 2016
Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins-What Determines the Site of Injury?Mona Doshi, Amit Lahoti, Farhad R Danesh, et al.
Kidney Medicine|April 20, 2026
Minimal Change Disease Following B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell TherapyKiran Shivaraj, Omar Mamlouk, Amanda Tchakarov, et al.
Clinical Kidney Journal|November 10, 2021
Hypophosphatemia in cancer patientsShreedhar Adhikari, Omar Mamlouk, Helbert Rondon-Berrios, et al.
Kidney Medicine|April 14, 2021
Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase InhibitorAnna Strasma, Howard Coke, Omar Mamlouk, et al.
The Journal of Biological Chemistry|February 12, 2011
MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathyJianyin Long, Yin Wang, Wenjian Wang, et al.
Pageof 9